Chemical Compound
Ritonavir Metabolite
CAS Registry Number
176655-55-3
Primary Record
Ritonavir Metabolite
- In stock
- 9,477 g
- Purity
- 99.8 %
- CAS
- 176655-55-3
Compound Identifiers & Properties
- CAS
- 176655-55-3
- PubChem CID
- 11467322
- SMILES
- CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)N)O
- Canonical SMILES
- CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@@H](N)Cc2ccccc2)C(C)C)cs1
Names & Synonyms
- Ritonavir Metabolite
- Ritonavir metabolite M1
- 176655-55-3
- RitonavirMetabolite
- Desthiazolylmethyloxycarbonyl Ritonavir
- Ritonavir Impurity 35
- UNII-34F916N28Z
- RefChem:199305
- C32H45N5O3S
- DTXSID00466763
- orb1990405
- 34F916N28Z
- CHEMBL3544848
- SCHEMBL13749205
- CTK4D6267
- DTXCID90417582
- HY-G0009
- A-98498
- 3578AH
- ARD168591
- MFCD09840395
- ZINC72131153
- AKOS030241613
- CS-4111
- CID11467322
- CID 11467322
- DA-72693
- MS-30408
- Ritonavir metabolite Desthiazolylmethyloxycarbonyl Ritonavir
- J1.837.568K
- Desthiazolylmethyloxycarbonyl Ritonavir (>85%)
- Desthiazolylmethyloxycarbonyl RitonavirHY-G0009
- F85155
- A924831
- (2S)-N-[(2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanamide
- Butanamide, N-[(1S,3S,4S)-4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-3-methyl-2-[[[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]-, (2S)-
- Q27256367
- (2S)-N-((1S,3S,4S)-4-Amino-1-benzyl-3-hydroxy-5-phenyl-pentyl)-2-(((2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl)amino)-3-methyl-butanamide
- Butanamide, N-((1S,3S,4S)-4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)-3-methyl-2-(((methyl((2-(1-methylethyl)-4-thiazolyl)methyl)amino)carbonyl)amino)-, (2S)-
- Butanamide, N-(4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)-3-methyl-2-(((methyl((2-(1-methylethyl)-4-thiazolyl)methyl)amino)carbonyl)amino)-, (1S-(1R*(R*),3R*,4R*))-
- N-[(2s,4s,5s)-5-Amino-4-Hydroxy-1,6-Diphenylhexan-2-Yl]-N~2~-(Methyl{[2-(Propan-2-Yl)-1,3-Thiazol-4-Yl]methyl}carbamoyl)-L-Valinamide
- (2S)-N-[(1S,3S,4S)-4-AMINO-3-HYDROXY-5-PHENYL-1-BENZYLPENTYL]-3-METHYL-2-[[[METHYL[[2-(1-METHYLETHYL)-THIAZOL-4-YL]METHYL]AMINO]CARBONYL]AMINO]BUTANAMIDE
- (2S)-N-[(1S,3S,4S)-4-amino-1-benzyl-3-hydroxy-5-phenyl-pentyl]-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-3-methyl-butanamide
- (2S)-N-[(1S,3S,4S)-4-Amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-3-methyl-2-[[[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]butanamide
- (2S)-N-[(2S,4S,5S)-5-AMINO-4-HYDROXY-1,6-DIPHENYLHEXAN-2-YL]-2-({[(2-ISOPROPYL-1,3-THIAZOL-4-YL)METHYL](METHYL)CARBAMOYL}AMINO)-3-METHYLBUTANAMIDE
- (2S)-N-[(2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamide
- (3R,5aS,6R,8aS,9R,12S,12aR)-Octahydro-3,6-dimethyl-9-(methyl-d3)-3,12-epox-12H-pyrano[4,3-j]-1,2-benzodioxepin-10(3H)-one
- (S)-N-((2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamide
- Butanamide, N-[(1S,3S,4S)-4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-3-methyl-2-[[[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]-, (2S)-; Butanamide, N-[4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-3-methyl-2-[[[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]-, [1S-[1R*(R*),3R*,4R*]]-; (2S)-N-[(1S,3S,4S)-4-Amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-3-methyl-2-[[[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]butanamide
- D0R
- N-[(1S,3S,4S)-1-Benzyl-3-hydroxy-4-amino-5-phenylpentyl]-Nalpha-[methyl(2-isopropyl-4-thiazolylmethyl)carbamoyl]valinamide